Status:
UNKNOWN
Using 32 - Gauge Needles With Lengths of 5 mm and 8 mm on Pain Post-injection, Leak and Blood Glucose
Lead Sponsor:
Baqiyatallah Medical Sciences University
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This is a Clinical crossover trial study. In this study, 100 patients with type II diabetes will be selected based on entry and exit criteria, then randomly divided into two equal groups (group "A" an...
Detailed Description
This is a Clinical crossover trial study. In this study, 100 patients with type II diabetes will be selected based on entry and exit criteria, then randomly divided into two equal groups (group "A" an...
Eligibility Criteria
Inclusion
- Having type II diabetes
- Use injectable insulin for at least two years
- BMI \>18
- Lack of mental illness and mental retardation
- Use insulin pen
Exclusion
- Lack of desire to participate in the study
- Having a skin problem in the injection site
Key Trial Info
Start Date :
May 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 25 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04460092
Start Date
May 25 2020
End Date
September 25 2020
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohammad Sadegh Bagheri Baghdasht
Tehran, Iran, 0